Legal Professionals: Get Listed!

What actions were taken by the FDA after Ketek was linked to severe liver complications?

By: LawInfo

The FDA approved a labeling supplement submitted by Aventis Pharmaceuticals as a "Changes Being Effected" (CBE) supplement, which highlights the 'Warnings' section of the labeling to raise attention to the risk of liver toxicity associated with Ketek.

Search LawInfo's Ketek Resources

Additional Ketek FAQs

Ketek Videos

How Do You File a Class Action Suit?

Change Your Location

Enter Your New Location:


(e.g., San Diego, CA or 92121 or 619)

Based on your IP Address, your default location is:

  • Area Code: 703
  • City: Ashburn
  • State: VA